Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-07-08 Purchase | 2022-07-13 9:27 pm | Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner | 19,270,476 | $2.2 | $42,395,047 | 76,616,270 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-07-11 Other | 2022-07-11 4:11 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Wagner Kristie Ann VP, Principal Fin & Acct Off | 73,400 | $0 | 0 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:11 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Wagner Kristie Ann VP, Principal Fin & Acct Off | 80,500 | $0 | 0 (Direct) | View |
| 2022-07-11 Other | 2022-07-11 4:10 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Triola Anna Diaz Chief Commercial Officer | 100,000 | $0 | 0 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:10 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Triola Anna Diaz Chief Commercial Officer | 125,000 | $0 | 0 (Direct) | View |
| 2022-07-07 Equity Swap | 2022-07-11 4:09 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer | 39,596 | $2.2 | 0 (Direct) | View |
| 2022-07-11 Other | 2022-07-11 4:09 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer | 180,023 | $0 | 0 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:09 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer | 150,000 | $0 | 0 (Direct) | View |
| 2022-07-07 Equity Swap | 2022-07-11 4:09 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief of Pharma Sciences & MFG | 17,572 | $2.2 | 0 (Direct) | View |
| 2022-07-11 Other | 2022-07-11 4:09 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief of Pharma Sciences & MFG | 88,333 | $0 | 0 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:09 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief of Pharma Sciences & MFG | 150,000 | $0 | 0 (Direct) | View |
| 2022-07-07 Equity Swap | 2022-07-11 4:08 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos President and CEO | 56,072 | $2.2 | 0 (Direct) | View |
| 2022-07-11 Other | 2022-07-11 4:08 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos President and CEO | 723,738 | $0 | 0 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:08 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos President and CEO | 478,500 | $0 | 0 (Direct) | View |
| 2022-07-07 Equity Swap | 2022-07-11 4:07 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer | 17,092 | $2.2 | 0 (Direct) | View |
| 2022-07-11 Other | 2022-07-11 4:07 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer | 169,043 | $0 | 0 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:07 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer | 150,000 | $0 | 0 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:07 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director | 27,500 | $2.2 | 0 (Direct) | View |
| 2022-07-07 Equity Swap | 2022-07-11 4:07 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director | 22,000 | $2.2 | 0 (Direct) | View |
| 2022-07-11 Other | 2022-07-11 4:07 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director | 28,307 | $0 | 0 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:06 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Mayer Howard Director | 27,500 | $2.2 | 0 (Direct) | View |
| 2022-07-07 Equity Swap | 2022-07-11 4:06 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Mayer Howard Director | 22,000 | $2.2 | 0 (Direct) | View |
| 2022-07-11 Other | 2022-07-11 4:06 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Mayer Howard Director | 23,500 | $0 | 0 (Direct) | View |
| 2022-07-07 Equity Swap | 2022-07-11 4:06 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel | 17,572 | $2.2 | 0 (Direct) | View |
| 2022-07-11 Other | 2022-07-11 4:06 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel | 70,833 | $0 | 0 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:06 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel | 150,000 | $0 | 0 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:05 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 27,500 | $2.2 | 0 (Direct) | View |
| 2022-07-07 Equity Swap | 2022-07-11 4:05 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 22,000 | $2.2 | 0 (Direct) | View |
| 2022-07-11 Other | 2022-07-11 4:05 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 37,583 | $0 | 0 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:04 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Berger Heather A. Director | 27,500 | $2.2 | 0 (Direct) | View |
| 2022-07-07 Equity Swap | 2022-07-11 4:04 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Berger Heather A. Director | 22,000 | $2.2 | 0 (Direct) | View |
| 2022-07-11 Other | 2022-07-11 4:04 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Berger Heather A. Director | 28,307 | $0 | 0 (Direct) | View |
| 2022-07-07 Equity Swap | 2022-07-11 4:03 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer | 17,572 | $2.2 | 0 (Direct) | View |
| 2022-07-11 Other | 2022-07-11 4:03 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer | 142,307 | $0 | 0 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:03 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer | 150,000 | $0 | 0 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-25 4:30 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Wagner Kristie Ann VP, Principal Fin & Acct Off | 10,000 | $0 | 80,500 (Direct) | View |
Ownership | 2022-02-25 4:30 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Wagner Kristie Ann VP, Principal Fin & Acct Off | 0 | $0 | 143,900 (Direct) | View |
| 2022-02-18 Other | 2022-02-23 1:05 pm | N/A 2022-08-18 | Entasis Therapeutics Holdings Inc. | ETTX | Innoviva Inc. Innoviva Strategic Opportunities LLC 10% Owner | 0 | $0 | 57,345,794 (Indirect) | View |
| 2021-07-16 Option Award | 2022-02-15 4:05 pm | N/A 2031-07-15 | Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer | 98,700 | $0 | 98,700 (Direct) | View |
| 2021-07-16 Disposition | 2022-02-15 4:05 pm | N/A 2025-08-11 | Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer | 145,359 | $0 | 98,700 (Direct) | View |
| 2021-07-16 Option Award | 2022-02-15 4:05 pm | N/A 2031-07-15 | Entasis Therapeutics Holdings Inc. | ETTX | Gutch Michael See Remarks | 75,404 | $0 | 75,404 (Direct) | View |
| 2021-07-16 Disposition | 2022-02-15 4:05 pm | N/A 2028-04-30 | Entasis Therapeutics Holdings Inc. | ETTX | Gutch Michael See Remarks | 102,462 | $0 | 75,404 (Direct) | View |
| 2021-07-16 Option Award | 2022-02-15 4:04 pm | N/A 2031-07-15 | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks | 33,333 | $0 | 33,333 (Direct) | View |
| 2021-07-16 Disposition | 2022-02-15 4:04 pm | N/A 2029-09-16 | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks | 40,000 | $0 | 33,333 (Direct) | View |
| 2021-07-16 Option Award | 2022-02-15 4:04 pm | N/A 2031-07-15 | Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos President and CEO | 326,114 | $0 | 326,114 (Direct) | View |
| 2021-07-16 Disposition | 2022-02-15 4:04 pm | N/A 2025-08-11 | Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos President and CEO | 457,283 | $0 | 326,114 (Direct) | View |
| 2021-07-16 Option Award | 2022-02-15 4:03 pm | N/A 2031-07-15 | Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer | 75,698 | $0 | 75,698 (Direct) | View |
| 2021-07-16 Disposition | 2022-02-15 4:03 pm | N/A 2025-08-11 | Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer | 103,473 | $0 | 75,698 (Direct) | View |
| 2021-07-16 Option Award | 2022-02-15 4:03 pm | N/A 2031-07-15 | Entasis Therapeutics Holdings Inc. | ETTX | Mayer Howard Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-07-16 Disposition | 2022-02-15 4:03 pm | N/A 2029-08-04 | Entasis Therapeutics Holdings Inc. | ETTX | Mayer Howard Director | 15,000 | $0 | 12,500 (Direct) | View |
| 2021-07-16 Option Award | 2022-02-15 4:02 pm | N/A 2031-07-15 | Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director | 17,307 | $0 | 17,307 (Direct) | View |
| 2021-07-16 Disposition | 2022-02-15 4:02 pm | N/A 2029-06-18 | Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director | 22,500 | $0 | 17,307 (Direct) | View |
| 2021-07-16 Option Award | 2022-02-15 4:02 pm | N/A 2031-07-15 | Entasis Therapeutics Holdings Inc. | ETTX | Behanna Heather Director | 17,307 | $0 | 17,307 (Direct) | View |
| 2021-07-16 Disposition | 2022-02-15 4:02 pm | N/A 2029-01-17 | Entasis Therapeutics Holdings Inc. | ETTX | Behanna Heather Director | 22,500 | $0 | 17,307 (Direct) | View |
| 2021-07-16 Option Award | 2022-02-15 4:01 pm | N/A 2031-07-15 | Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer | 92 | $0 | 92,307 (Direct) | View |
| 2021-07-16 Disposition | 2022-02-15 4:01 pm | N/A 2029-11-03 | Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer | 120,000 | $0 | 92,307 (Direct) | View |
| 2021-07-16 Option Award | 2022-02-15 4:01 pm | N/A 2031-07-15 | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 26,583 | $0 | 26,583 (Direct) | View |
| 2021-07-16 Disposition | 2022-02-15 4:01 pm | N/A 2028-04-30 | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 34,560 | $0 | 26,583 (Direct) | View |
| 2021-07-16 Option Award | 2022-02-15 4:00 pm | N/A 2031-07-15 | Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel | 20,833 | $0 | 20,833 (Direct) | View |
| 2021-07-16 Disposition | 2022-02-15 4:00 pm | N/A 2029-04-25 | Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel | 25,000 | $0 | 20,833 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:05 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Tommasi Ruben Chief Scientific Officer | 125,000 | $0 | 189,596 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:05 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Gutch Michael See Remarks | 125,000 | $0 | 167,572 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:04 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew See Remarks | 125,000 | $0 | 167,572 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:04 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Perros Manoussos See Remarks | 125,000 | $0 | 534,572 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:03 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Mueller John Patrick Chief Development Officer | 125,000 | $0 | 167,092 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:03 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Mayer Howard Director | 27,500 | $0 | 49,500 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:02 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Behanna Heather Director | 27,500 | $0 | 49,500 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:02 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Keiley Elizabeth M General Counsel | 125,000 | $0 | 167,572 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:01 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Meek David D. Director | 27,500 | $0 | 49,500 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:01 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 27,500 | $0 | 49,500 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:00 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Altarac David Chief Medical Officer | 125,000 | $0 | 167,572 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:00 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Triola Anna Diaz Chief Commercial Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2021-11-02 Tax Withholding | 2021-11-03 4:05 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Ronsheim Matthew Chief, Pharma Sciences & MFG. | 3,669 | $2.94 | 42,572 (Direct) | View |